HAVN Life Sciences Inc. announced the departure of Messrs. Victor Neufeld and Dennis Staudt, respectively, as Directors of the Company, effective immediately. The Company announced that Tim Moore, Chief Executive Officer and Director, has been appointed Chairman of the Board, and that Gordon Clissold, the Company's Chief Financial Officer, has been appointed as a Director.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | -.--% | +20.00% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 628K | |
+53.79% | 55.7B | |
+41.08% | 39.91B | |
-5.21% | 39.57B | |
-5.56% | 28.16B | |
+16.37% | 26.3B | |
-20.21% | 18.94B | |
+33.01% | 12.17B | |
+26.53% | 12.12B | |
+2.58% | 12.12B |
- Stock Market
- Equities
- HAVN Stock
- News HAVN Life Sciences Inc.
- HAVN Life Sciences Inc. Announces Board Changes